BA
VMD icon

Bard Associates’s Viemed Healthcare VMD Stock Holding History

Bard Associates’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.13M Buy
339,941
+597
+0.2% +$4.97K 0.79% 44
2025
Q4 		$2.52M Sell
339,344
-1,653
-0.5% -$11.3K 0.65% 53
2025
Q3 		$2.32M Buy
340,997
+4,669
+1% +$31.6K 0.61% 54
2025
Q2 		$2.32M Sell
336,328
-13,295
-4% -$90.2K 0.75% 47
2025
Q1 		$2.55M Buy
349,623
+97
+0% +$762 0.95% 37
2024
Q4 		$2.8M Buy
349,526
+4,474
+1% +$38.8K 0.95% 34
2024
Q3 		$2.53M Buy
345,052
+3,762
+1% +$26.9K 0.86% 42
2024
Q2 		$2.24M Sell
341,290
-925
-0.3% -$6.97K 0.86% 42
2024
Q1 		$3.23M Buy
342,215
+3,880
+1% +$33.3K 1.16% 24
2023
Q4 		$2.66M Buy
338,335
+303,880
+882% +$2.2M 1.01% 33
2023
Q3 		$232K Buy
34,455
+10,530
+44% +$86.3K 0.1% 150
2023
Q2 		$234K Sell
23,925
-68
-0.3% -$691 0.09% 151
2023
Q1 		$232K Buy
23,993
+1,000
+4% +$8.72K 0.1% 156
2022
Q4 		$174K Buy
22,993
+2,000
+10% +$13.5K 0.07% 165
2022
Q3 		$126K Buy
20,993
+100
+0.5% +$642 0.06% 165
2022
Q2 		$112K Buy
20,893
+3,000
+17% +$16.2K 0.05% 170
2022
Q1 		$89K Buy
17,893
+168
+0.9% +$780 0.03% 178
2021
Q4 		$93K Hold
17,725
– – 0.03% 174
2021
Q3 		$98K Buy
17,725
+2,000
+13% +$13K 0.03% 168
2021
Q2 		$112K Buy
+15,725
New +$136K 0.04% 167

Other funds holding VMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Bard Associates's VMD Position: Q1 2026 in Review

Bard Associates increased its Viemed Healthcare (VMD) stake by 0.18% in Q1 2026, buying an estimated $4.97K and bringing the position to 339,941 shares worth $3.13M. The position accounts for 0.79% of the portfolio, ranked #44.

Bard Associates first reported a position in VMD in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.23M in Q1 2024. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Bard Associates held 339,941 shares of Viemed Healthcare worth $3.13M as of Q1 2026.
  • Bard Associates bought 597 Viemed Healthcare shares in Q1 2026, an estimated $4.97K.
  • Viemed Healthcare made up 0.79% of Bard Associates's portfolio in Q1 2026, its #44 holding.
  • Bard Associates first reported a position in Viemed Healthcare in Q2 2021 and has held it in 20 quarters since.
  • Bard Associates's Viemed Healthcare position peaked at $3.23M in Q1 2024.
  • 149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Bard Associates's 13F filing for Q1 2026, filed 8 May 2026.